Infectious Diseases Pharmacotherapy Residency Call for Grant Applications 2010-2011

Society of Infectious Diseases Pharmacists

Call For Grant Applications To Fund

Infectious Diseases Pharmacotherapy Residency

The Board of Directors of the Society of Infectious Diseases Pharmacists (SIDP) is pleased to announce the availabil­ity of funding by Pfizer Pharmaceuticals to support an Infectious Diseases Pharmacotherapy Residency for the period of July 2010 through June 2011.

The intent of this funding is to foster the development of advanced training opportunities for clinical pharmacy practitioners committed to the practice area of infectious diseases. Please note that staffing by the resident is not allowed.

SIDP will provide funding to support resident salaries plus fringe benefits and will include $1,500 travel support to attend the annual SIDP meeting (total grant not to exceed $40,000 per award).

SIDP members who have received a SIDP Residency Award as either Residency Director or as a preceptor at the same or affiliated institution in the past two of three residency funding cycles, and current members of the SIDP Board of Directors are ineligible for these awards.

Preceptors awarded residency funding must send a copy of the letter of acceptance from the resident plus CV and proof of PGY1 residency training or summary of pharmacy practice experiences by the resident applicant to SIDP Headquarters no later than May 7, 2010 or the award will be rescinded. A midpoint and final report of the resident’s activities (rotations, presentations, research and publications) is also required.

Completed applications should be electronically submitted:

Proposals should be converted to a single PDF file adhering to the format described below. The PDF file of the proposal is then submitted via the proposal submission portal on the SIDP website:

http://www.sidp.org/index.php?module=pagesetter&func=pubedit&tid=9

Proposals must be submitted online no later than 5 PM E.S.T. on February 26, 2010. Applications not submitted through the SIDP website portal, or submitted after the application deadline, will not be considered.

The Board of Directors will make decisions on the applications no later than March 26, 2010.

The Society of Infectious Diseases Pharmacists worked jointly with the American Society of Health-Systems Pharmacists (ASHP) in the development of the current ASHP Educational Outcomes, Goals, and Objectives for Postgraduate Year Two (PGY2) Pharmacy Residencies in Infectious Diseases.

The PGY2 pharmacy residency in infectious diseases is designed to transition PGY1 residency graduates from generalist practice to specialized practice focused on the care of patients with infectious diseases. Residency graduates are equipped to participate as integral members of interdisciplinary teams caring for patients with infectious diseases, assuming responsibility for their pharmaceutical care.

ASHP Educational Outcomes, Goals, and Objectives for Postgraduate Year Two
(PGY2) Pharmacy Residencies in Infectious Diseases. Prepared in collaboration with the American College of Clinical Pharmacy and the Society of Infectious Diseases Pharmacists and endorsed by the SIDP Board of Directors.

SIDP endorses these published ASHP Educational Outcomes, Goals, and Objectives for Postgraduate Year Two (PGY2) Pharmacy Residencies in Infectious Diseases and supports their utility for any residency funded by SIDP.

Criteria for Award Evaluation

Award Recipient:

1. Is a full member of SIDP at the time of application, and not currently serving on the Board of Directors.
2. Has completed advanced training in ID pharmacotherapy practice or has at least
3 years of clinical experience as an active clinical practitioner in ID pharmacotherapy.
3. Has experience in precepting or directing postgraduate training.

Institution:

1. Is capable of providing a full range of training experiences which may include inpatient care, outpatient care, pediatrics, HIV, microbiology laboratory, infection control, and a longitudinal experience.
2. The institution’s administration is supportive of the residency training program, as indicated in a letter stating its support.
3. Has adequate space and resources identified to support resident training.
4. Existing pharmaceutical services to support specialty training program.

Residency Candidate:

1. Possesses a Doctor of Pharmacy degree from an ACPE-accredited college of pharmacy.
2. Has completed a PGY1 Residency, is currently in training in a PGY1 residency program that will be completed before the start of this program, or has equivalent pharmacy practice experience.

Residency Program

1. Meets the ASHP Accreditation Standard for Postgraduate Year Two (PGY2) Pharmacy Residency Programs. ASHP Commission on Credentialing; American Society of Health-System Pharmacists. URL: http://www.ashp.org/Import/ACCREDITATION/ResidencyAccreditation/RegulationsStandards.aspx.  Available from Internet. Accessed 2010, August 25.

Required Elements of Application

1. A letter of application from individual who will serve as residency director.
2. A letter of support from Director of Pharmacy Services at each clinical facility where residency training will occur.
3. Letters of support from Infectious Diseases physicians on staff who will work with the resident during the ID residency.
4. A current curriculum vitae for the residency director and for each individual who will serve as a preceptor for residency training experience.
5. A description of each practice site and outline of specific patient-care functions and responsibilities of the preceptor for each of these sites.
6. A description of how resident will be recruited and criteria to be used in residency candidate selection process.
7. A list of any previous ID resident(s) trained by residency director to include a description of any residency projects completed and their current practice site(s) (if known).
8. A proposed annual training schedule for the ID resident.
9. A comprehensive sample of individualized learning objectives developed for each training period.
10. A description of process to be used for evaluation of the ID resident and examples of any evaluation instruments or forms that will be used.
11. A description of process used for resident evaluation of preceptors and overall training experience.
12. A list of potential projects for ID resident.

If there are questions regarding the application process, please contact David S. Burgess, Pharm.D., FCCP at (210) 567-8329 or by email at burgessd@uthscsa.edu.